NasdaqGS - Nasdaq Real Time Price USD
Denali Therapeutics Inc. (DNLI)
13.24
-0.30
(-2.22%)
At close: May 30 at 4:00:02 PM EDT
13.24
+0.00
+(0.01%)
After hours: May 30 at 4:21:56 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 14 | 15 | 14 |
| Avg. Estimate | -0.73 | -0.76 | -3.05 | -2.79 |
| Low Estimate | -0.93 | -0.95 | -3.61 | -3.68 |
| High Estimate | -0.43 | -0.64 | -2.35 | -1.98 |
| Year Ago EPS | -0.59 | -0.63 | -2.57 | -3.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 17 | 17 |
| Avg. Estimate | 6.04M | 4.78M | 20.63M | 109.34M |
| Low Estimate | -- | -- | -- | 9.56M |
| High Estimate | 50M | 34.55M | 138.2M | 284.12M |
| Year Ago Sales | -- | -- | -- | 20.63M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 429.87% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.69 | -0.63 | -0.85 | -0.7 |
| EPS Actual | -0.59 | -0.63 | -0.67 | -0.78 |
| Difference | 0.1 | 0 | 0.18 | -0.08 |
| Surprise % | 14.95% | 0.30% | 20.79% | -10.75% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.73 | -0.76 | -3.05 | -2.79 |
| 7 Days Ago | -0.73 | -0.76 | -3.03 | -2.76 |
| 30 Days Ago | -0.71 | -0.74 | -2.87 | -2.66 |
| 60 Days Ago | -0.71 | -0.74 | -2.86 | -2.61 |
| 90 Days Ago | -0.79 | -0.63 | -2.96 | -2.34 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | 1 | 3 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 12 | 10 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DNLI | -24.41% | -20.91% | -18.72% | 8.67% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | B of A Securities: Buy to Buy | 5/19/2025 |
| Maintains | Baird: Outperform to Outperform | 5/8/2025 |
| Maintains | Wedbush: Outperform to Outperform | 5/7/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/7/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/10/2025 |
| Reiterates | B. Riley Securities: Buy to Buy | 3/5/2025 |
Related Tickers
ALEC Alector, Inc.
1.3300
-6.34%
APLS Apellis Pharmaceuticals, Inc.
16.93
-2.76%
RGNX REGENXBIO Inc.
8.85
-1.34%
CYTK Cytokinetics, Incorporated
31.02
-0.96%
PTCT PTC Therapeutics, Inc.
48.52
-0.76%
RARE Ultragenyx Pharmaceutical Inc.
34.03
-2.85%
IDYA IDEAYA Biosciences, Inc.
19.89
-0.80%
WVE Wave Life Sciences Ltd.
6.01
-3.69%
PRAX Praxis Precision Medicines, Inc.
38.55
+0.26%
BCYC Bicycle Therapeutics plc
8.22
-5.52%